Investor Presentaiton slide image

Investor Presentaiton

USA - Moving up the value chain.... Strengthening Presence with customers & operational improvements Growth drivers – pipeline size and diversification Growth drivers - Business Development Among top 3 players in 14 molecules 11 products with sales > 5 million USD in 15-16 Increasing # of projects - 53 ANDA approvals + 19 pending + 44 Products under development. Adding 18-20 products per year (earlier 10-12 per year) Augment pipeline with external partners Strengths in multiple channels with anchor customers Improve operational excellence internalize warehousing Increase presence in New segments - Dermatology, Oncology & Ophthalmology. Complex Generics First to file projects M&A
View entire presentation